Search

everythinglearnresearchcommunity

for

Search:↓

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

The workshop aimed to improve hair loss disorder diagnosis and understanding.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

New hair products are being developed to keep hair and scalp healthy for everyone.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

A 15-year-old with KID syndrome developed a rare skin condition called PEHFN.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.